Table 2.
Clinical and microbiologic characteristics of Comamonas kerstersii bacteremia in humans.
| Age | Sex | Clinical presentation | Underlying conditions | Predisposing conditions | Pathogens identified | Antibiotic treatment | Outcome | Reference |
|---|---|---|---|---|---|---|---|---|
| 65 | M | Abdominal pain, vomiting, diarrhea, fever, chills | Diabetes | Diverticulosis, ingested river water | Comamonas kerstersii, Bacteroides fragilis | Ciprofloxacin, then imipenem-cilastatin after identification | Recovered | [6] |
| 31 | M | Abdominal pain, nausea, vomiting, fever | None reported | Perforated appendicitis with abdominal abscess, acute peritonitis | Comamonas kerstersii | Cefuroxime axetil, then cefuroxime and metronidazole at discharge | Complete recovery | [10] |
| 16 | M | Abdominal pain, fever, nausea, vomiting | None reported | Acute appendicitis, appendicular abscess | Comamonas kerstersii | Ampicillin-sulbactam and metronidazole, then piperacillin-tazobactam after identification | Recovered | [13] |
| 82 | M | Chills, rigours, constipation, fever | Type 2 diabetes, diabetic neuropathy, dyslipidemia, colon tubular adenoma, tubulovillous adenoma | None | Comamonas kerstersii | Piperacillin-tazobactam, then ceftriaxone and amoxicillin-clavulanic acid at discharge | Recovered | Present case |